During the last session, Innoviva Inc (NASDAQ:INVA)’s traded shares were 0.76 million, with the beta value of the company hitting 0.39. At the end of the trading day, the stock’s price was $18.77, reflecting an intraday loss of -1.52% or -$0.29. The 52-week high for the INVA share is $22.00, that puts it down -17.21 from that peak though still a striking 11.19% gain since the share price plummeted to a 52-week low of $16.67. The company’s market capitalization is $1.18B, and the average intraday trading volume over the past 10 days was 1.01 million shares, and the average trade volume was 849.20K shares over the past three months.
Innoviva Inc (INVA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. INVA has a Sell rating from 1 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.
Innoviva Inc (NASDAQ:INVA) trade information
Innoviva Inc (INVA) registered a -1.52% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.52% in intraday trading to $18.77, hitting a weekly high. The stock’s 5-day price performance is -2.29%, and it has moved by -12.82% in 30 days. Based on these gigs, the overall price performance for the year is 8.18%. The short interest in Innoviva Inc (NASDAQ:INVA) is 9.65 million shares and it means that shorts have 10.42 day(s) to cover.
The consensus price target of analysts on Wall Street is $55, which implies an increase of 65.87% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $55 and $55 respectively. As a result, INVA is trading at a discount of -193.02% off the target high and -193.02% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -24.00%. While earnings are projected to return 110.60% in 2025, the next five years will return 93.72% per annum.
INVA Dividends
Innoviva Inc is due to release its next quarterly earnings on 2025-May-07. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Innoviva Inc (NASDAQ:INVA)’s Major holders
Innoviva Inc insiders own 0.98% of total outstanding shares while institutional holders control 110.22%, with the float percentage being 111.31%. BLACKROCK INC. is the largest shareholder of the company, while 355.0 institutions own stock in it. As of 2024-06-30, the company held over 9.63 million shares (or 15.4006% of all shares), a total value of $157.92 million in shares.
The next largest institutional holding, with 7.28 million shares, is of SARISSA CAPITAL MANAGEMENT LP’s that is approximately 11.6384% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $119.34 million.
Also, the Mutual Funds coming in first place with the largest holdings of Innoviva Inc (INVA) shares are PUTNAM GLOBAL HEALTH CARE FUND and iShares Trust-iShares Core S&P Small-Cap ETF . Data provided on Feb 28, 2025 indicates that PUTNAM GLOBAL HEALTH CARE FUND owns about 3.34 shares. This amounts to just over 5.31 percent of the company’s overall shares, with a $62.61 million market value. The same data shows that the other fund manager holds slightly less at 3.3, or about 5.25% of the stock, which is worth about $61.89 million.
